Trial Outcomes & Findings for ICE-T Pain Regimen for Total Laparoscopic Hysterectomy (NCT NCT03987022)

NCT ID: NCT03987022

Last Updated: 2025-01-24

Results Overview

Visual Analog Scores (VAS) Scores in the morning of post op day 1 (\~24 hours after surgery) The scale is from 0 to 10 (0=no pain and 10=being worst pain ever)

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

66 participants

Primary outcome timeframe

Morning of post operative day 1 (~24 hours after surgery)

Results posted on

2025-01-24

Participant Flow

Prior to surgery, patients will be asked to participate in the study in their private patient rooms or in medical clinic.

111 patients were assessed for eligibility, but 45 were excluded (30 did not meet inclusion criteria, and 15 declined to participate). Therefore, 66 patients were randomized.

Participant milestones

Participant milestones
Measure
"ICE-T" Opioid Sparing Regimen
At the end of surgery patients will receive 30mg of intravenous (IV) toradol. Once out of the post anesthesia care unit (PACU) patients will receive 1. ICE PACKS applied to the surgical sites every hour for 20 minutes Around the clock (ATC) until discharge. 2. 6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge. 3. Once out of the PACU will receive 1 gram of Tylenol per os (PO) every 6 hours for a total of 4 grams daily ATC until discharge 4. Patients will receive dilaudid 0.2mg IV every 3 hours as needed (PRN) for breakthrough pain. 5. Patients will be discharged home with (PO) Tylenol and PO toradol as needed (PRN).
STANDARD Postoperative Regimen
Once out of the PACU patients will receive "Standard" postoperative regimen, which includes: 1. Motrin 600mg PO every 4 hours PRN pain scale 1-3 pain 2. Percocet 1 tab PO every 4-6 hours PRN pain scale 4-6 pain 3. Percocet 2 tabs PO every 7-10 hours PRN pain scale 7-10 pain 4. Patients will receive dilaudid 0.2mg IV every 3 hours PRN for breakthrough pain. 5. Patients will be discharged home with Motrin and Percocet for pain PRN.
Overall Study
STARTED
36
30
Overall Study
COMPLETED
33
28
Overall Study
NOT COMPLETED
3
2

Reasons for withdrawal

Reasons for withdrawal
Measure
"ICE-T" Opioid Sparing Regimen
At the end of surgery patients will receive 30mg of intravenous (IV) toradol. Once out of the post anesthesia care unit (PACU) patients will receive 1. ICE PACKS applied to the surgical sites every hour for 20 minutes Around the clock (ATC) until discharge. 2. 6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge. 3. Once out of the PACU will receive 1 gram of Tylenol per os (PO) every 6 hours for a total of 4 grams daily ATC until discharge 4. Patients will receive dilaudid 0.2mg IV every 3 hours as needed (PRN) for breakthrough pain. 5. Patients will be discharged home with (PO) Tylenol and PO toradol as needed (PRN).
STANDARD Postoperative Regimen
Once out of the PACU patients will receive "Standard" postoperative regimen, which includes: 1. Motrin 600mg PO every 4 hours PRN pain scale 1-3 pain 2. Percocet 1 tab PO every 4-6 hours PRN pain scale 4-6 pain 3. Percocet 2 tabs PO every 7-10 hours PRN pain scale 7-10 pain 4. Patients will receive dilaudid 0.2mg IV every 3 hours PRN for breakthrough pain. 5. Patients will be discharged home with Motrin and Percocet for pain PRN.
Overall Study
Lost to Follow-up
2
2
Overall Study
Withdrawal by Subject
1
0

Baseline Characteristics

66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
ICE-T
n=36 Participants
Toradol and Tylenol were given as pain management post-operative of total laparoscopic hysterectomy
Standard of Care (Control)
n=30 Participants
Received routine pain management postoperative of laparoscopic hysterectomy
Total
n=66 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Age, Categorical
Between 18 and 65 years
36 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
30 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
66 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Age, Categorical
>=65 years
0 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Sex: Female, Male
Female
36 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
30 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
66 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Sex: Female, Male
Male
0 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
4 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Ethnicity (NIH/OMB)
Not Hispanic or Latino
32 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
30 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
62 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Race (NIH/OMB)
Asian
2 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
1 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
3 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Race (NIH/OMB)
Black or African American
19 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
18 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
37 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Race (NIH/OMB)
White
11 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
11 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
22 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Race (NIH/OMB)
Unknown or Not Reported
4 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
4 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Body Mass Index
31.0 kg/m^2
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
29.8 kg/m^2
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
30.8 kg/m^2
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Depression/Anxiety
1 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
1 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
2 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Current Smoker
7 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
9 Participants
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
16 Participants
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
Charlson Comorbidity Index
0 Index
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Index
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
0 Index
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
STOP-BANG Score
1.0 scores on a scale
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
1.0 scores on a scale
n=7 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
1.0 scores on a scale
n=5 Participants • 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).

PRIMARY outcome

Timeframe: Morning of post operative day 1 (~24 hours after surgery)

Population: This population are participants that are approximately 24 hours post Total Laparoscopic Hysterectomy procedure. 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up).

Visual Analog Scores (VAS) Scores in the morning of post op day 1 (\~24 hours after surgery) The scale is from 0 to 10 (0=no pain and 10=being worst pain ever)

Outcome measures

Outcome measures
Measure
"ICE-T" Opioid Sparing Regimen
n=32 Participants
At the end of surgery patients will receive 30mg of intravenous (IV) toradol. Once out of the post anesthesia care unit (PACU) patients will receive 1. ICE PACKS applied to the surgical sites every hour for 20 minutes Around the clock (ATC) until discharge. 2. 6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge. 3. Once out of the PACU will receive 1 gram of Tylenol per os (PO) every 6 hours for a total of 4 grams daily ATC until discharge 4. Patients will receive dilaudid 0.2mg IV every 3 hours as needed (PRN) for breakthrough pain. 5. Patients will be discharged home with (PO) Tylenol and PO toradol as needed (PRN). 6. If patient's requested additional opioids prior to POD4 they were given a supplemental narcotic prescription to ensure adequate pain control
STANDARD Postoperative Regimen
n=28 Participants
Once out of the PACU patients will receive "Standard" postoperative regimen, which includes: 1. Motrin 600mg PO every 4 hours PRN pain scale 1-3 pain 2. Percocet 1 tab PO every 4-6 hours PRN pain scale 4-6 pain 3. Percocet 2 tabs PO every 7-10 hours PRN pain scale 7-10 pain 4. Patients will receive dilaudid 0.2mg IV every 3 hours PRN for breakthrough pain. 5. Patients will be discharged home with Motrin and Percocet for pain PRN.
POD1 Visual Analog Pain (VAS) Score
5.8 Score on a scale
Interval 3.0 to 7.0
5 Score on a scale
Interval 3.0 to 6.0

SECONDARY outcome

Timeframe: Postoperative Day 1

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up).

QoR-40 is a quality of recovery 40-item questionnaire based on how the patient has felt in the past 24 hours. It provides a global score and sub scores across five dimensions: patient support, comfort, emotions, physical independence, and pain; each item is graded on a five-point Likert scale. QoR-40 scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery). It is a measure of postoperative quality of recovery in a range of clinical and research situations.

Outcome measures

Outcome measures
Measure
"ICE-T" Opioid Sparing Regimen
n=32 Participants
At the end of surgery patients will receive 30mg of intravenous (IV) toradol. Once out of the post anesthesia care unit (PACU) patients will receive 1. ICE PACKS applied to the surgical sites every hour for 20 minutes Around the clock (ATC) until discharge. 2. 6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge. 3. Once out of the PACU will receive 1 gram of Tylenol per os (PO) every 6 hours for a total of 4 grams daily ATC until discharge 4. Patients will receive dilaudid 0.2mg IV every 3 hours as needed (PRN) for breakthrough pain. 5. Patients will be discharged home with (PO) Tylenol and PO toradol as needed (PRN). 6. If patient's requested additional opioids prior to POD4 they were given a supplemental narcotic prescription to ensure adequate pain control
STANDARD Postoperative Regimen
n=28 Participants
Once out of the PACU patients will receive "Standard" postoperative regimen, which includes: 1. Motrin 600mg PO every 4 hours PRN pain scale 1-3 pain 2. Percocet 1 tab PO every 4-6 hours PRN pain scale 4-6 pain 3. Percocet 2 tabs PO every 7-10 hours PRN pain scale 7-10 pain 4. Patients will receive dilaudid 0.2mg IV every 3 hours PRN for breakthrough pain. 5. Patients will be discharged home with Motrin and Percocet for pain PRN.
POD1 Quality of Recovery Score
161.5 Score on a scale
Interval 147.5 to 179.0
162.5 Score on a scale
Interval 155.0 to 179.5

SECONDARY outcome

Timeframe: Total narcotic use from intra-op to 24 hours post-op

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The postoperative day 1 analysis outcomes included n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up. The subjects who chose same-day discharge were excluded from the analysis of total narcotic use within 24 hours post-op due to differences in reporting and access to medications. The analysis of this variable included n=27 ICE-T arm and n=23 Standard arm.

Total amount of narcotic in morphine equivalents administered to patients who were admitted for overnight extended recovery and/or observation. This includes narcotics given intra-operatively, in the post-anesthesia care unit and during their inpatient stay up until 24 hours postop.

Outcome measures

Outcome measures
Measure
"ICE-T" Opioid Sparing Regimen
n=27 Participants
At the end of surgery patients will receive 30mg of intravenous (IV) toradol. Once out of the post anesthesia care unit (PACU) patients will receive 1. ICE PACKS applied to the surgical sites every hour for 20 minutes Around the clock (ATC) until discharge. 2. 6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge. 3. Once out of the PACU will receive 1 gram of Tylenol per os (PO) every 6 hours for a total of 4 grams daily ATC until discharge 4. Patients will receive dilaudid 0.2mg IV every 3 hours as needed (PRN) for breakthrough pain. 5. Patients will be discharged home with (PO) Tylenol and PO toradol as needed (PRN). 6. If patient's requested additional opioids prior to POD4 they were given a supplemental narcotic prescription to ensure adequate pain control
STANDARD Postoperative Regimen
n=23 Participants
Once out of the PACU patients will receive "Standard" postoperative regimen, which includes: 1. Motrin 600mg PO every 4 hours PRN pain scale 1-3 pain 2. Percocet 1 tab PO every 4-6 hours PRN pain scale 4-6 pain 3. Percocet 2 tabs PO every 7-10 hours PRN pain scale 7-10 pain 4. Patients will receive dilaudid 0.2mg IV every 3 hours PRN for breakthrough pain. 5. Patients will be discharged home with Motrin and Percocet for pain PRN.
1st 24hr Total Dose of Narcotic
77 oral morphine milligram equivalents
Interval 54.3 to 101.0
111.5 oral morphine milligram equivalents
Interval 84.8 to 121.3

SECONDARY outcome

Timeframe: Post-operative Day 1

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up).

Length of hospital stay measured in the number of nights spent at the hospital. Subjects were given the option for same-day discharge home from the PACU or overnight inpatient observation.

Outcome measures

Outcome measures
Measure
"ICE-T" Opioid Sparing Regimen
n=32 Participants
At the end of surgery patients will receive 30mg of intravenous (IV) toradol. Once out of the post anesthesia care unit (PACU) patients will receive 1. ICE PACKS applied to the surgical sites every hour for 20 minutes Around the clock (ATC) until discharge. 2. 6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge. 3. Once out of the PACU will receive 1 gram of Tylenol per os (PO) every 6 hours for a total of 4 grams daily ATC until discharge 4. Patients will receive dilaudid 0.2mg IV every 3 hours as needed (PRN) for breakthrough pain. 5. Patients will be discharged home with (PO) Tylenol and PO toradol as needed (PRN). 6. If patient's requested additional opioids prior to POD4 they were given a supplemental narcotic prescription to ensure adequate pain control
STANDARD Postoperative Regimen
n=28 Participants
Once out of the PACU patients will receive "Standard" postoperative regimen, which includes: 1. Motrin 600mg PO every 4 hours PRN pain scale 1-3 pain 2. Percocet 1 tab PO every 4-6 hours PRN pain scale 4-6 pain 3. Percocet 2 tabs PO every 7-10 hours PRN pain scale 7-10 pain 4. Patients will receive dilaudid 0.2mg IV every 3 hours PRN for breakthrough pain. 5. Patients will be discharged home with Motrin and Percocet for pain PRN.
Length of Stay
1 nights
Interval 1.0 to 1.0
1 nights
Interval 1.0 to 1.0

SECONDARY outcome

Timeframe: VAS Scores at 4 days post-surgery.

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).

Visual Analog Scores 4 days post-surgery. VAS pain score of 0 to a score of worst pain indicating a score of 10 (0=no pain and 10=being worst pain ever)

Outcome measures

Outcome measures
Measure
"ICE-T" Opioid Sparing Regimen
n=29 Participants
At the end of surgery patients will receive 30mg of intravenous (IV) toradol. Once out of the post anesthesia care unit (PACU) patients will receive 1. ICE PACKS applied to the surgical sites every hour for 20 minutes Around the clock (ATC) until discharge. 2. 6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge. 3. Once out of the PACU will receive 1 gram of Tylenol per os (PO) every 6 hours for a total of 4 grams daily ATC until discharge 4. Patients will receive dilaudid 0.2mg IV every 3 hours as needed (PRN) for breakthrough pain. 5. Patients will be discharged home with (PO) Tylenol and PO toradol as needed (PRN). 6. If patient's requested additional opioids prior to POD4 they were given a supplemental narcotic prescription to ensure adequate pain control
STANDARD Postoperative Regimen
n=23 Participants
Once out of the PACU patients will receive "Standard" postoperative regimen, which includes: 1. Motrin 600mg PO every 4 hours PRN pain scale 1-3 pain 2. Percocet 1 tab PO every 4-6 hours PRN pain scale 4-6 pain 3. Percocet 2 tabs PO every 7-10 hours PRN pain scale 7-10 pain 4. Patients will receive dilaudid 0.2mg IV every 3 hours PRN for breakthrough pain. 5. Patients will be discharged home with Motrin and Percocet for pain PRN.
POD4 VAS Scores
3 Score on a scale
Interval 1.5 to 5.0
4 Score on a scale
Interval 2.5 to 5.0

SECONDARY outcome

Timeframe: Postoperative Day 4

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).

QoR-40 is a quality of recovery 40-item questionnaire based on how the patient has felt in the past 24 hours. It provides a global score and sub scores across five dimensions: patient support, comfort, emotions, physical independence, and pain; each item is graded on a five-point Likert scale. QoR-40 scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery). It is a measure of postoperative quality of recovery in a range of clinical and research situations.

Outcome measures

Outcome measures
Measure
"ICE-T" Opioid Sparing Regimen
n=29 Participants
At the end of surgery patients will receive 30mg of intravenous (IV) toradol. Once out of the post anesthesia care unit (PACU) patients will receive 1. ICE PACKS applied to the surgical sites every hour for 20 minutes Around the clock (ATC) until discharge. 2. 6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge. 3. Once out of the PACU will receive 1 gram of Tylenol per os (PO) every 6 hours for a total of 4 grams daily ATC until discharge 4. Patients will receive dilaudid 0.2mg IV every 3 hours as needed (PRN) for breakthrough pain. 5. Patients will be discharged home with (PO) Tylenol and PO toradol as needed (PRN). 6. If patient's requested additional opioids prior to POD4 they were given a supplemental narcotic prescription to ensure adequate pain control
STANDARD Postoperative Regimen
n=23 Participants
Once out of the PACU patients will receive "Standard" postoperative regimen, which includes: 1. Motrin 600mg PO every 4 hours PRN pain scale 1-3 pain 2. Percocet 1 tab PO every 4-6 hours PRN pain scale 4-6 pain 3. Percocet 2 tabs PO every 7-10 hours PRN pain scale 7-10 pain 4. Patients will receive dilaudid 0.2mg IV every 3 hours PRN for breakthrough pain. 5. Patients will be discharged home with Motrin and Percocet for pain PRN.
POD4 Quality of Recovery
179.5 Score on a scale
Interval 164.5 to 190.5
177.0 Score on a scale
Interval 168.0 to 190.0

SECONDARY outcome

Timeframe: Data collected as of postoperative day 4

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).

Patient's satisfaction with their pain management as of postoperative day 4, rated on a scale of 1 - 10, where 1 is very dissatisfied and 10 is very satisfied.

Outcome measures

Outcome measures
Measure
"ICE-T" Opioid Sparing Regimen
n=29 Participants
At the end of surgery patients will receive 30mg of intravenous (IV) toradol. Once out of the post anesthesia care unit (PACU) patients will receive 1. ICE PACKS applied to the surgical sites every hour for 20 minutes Around the clock (ATC) until discharge. 2. 6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge. 3. Once out of the PACU will receive 1 gram of Tylenol per os (PO) every 6 hours for a total of 4 grams daily ATC until discharge 4. Patients will receive dilaudid 0.2mg IV every 3 hours as needed (PRN) for breakthrough pain. 5. Patients will be discharged home with (PO) Tylenol and PO toradol as needed (PRN). 6. If patient's requested additional opioids prior to POD4 they were given a supplemental narcotic prescription to ensure adequate pain control
STANDARD Postoperative Regimen
n=23 Participants
Once out of the PACU patients will receive "Standard" postoperative regimen, which includes: 1. Motrin 600mg PO every 4 hours PRN pain scale 1-3 pain 2. Percocet 1 tab PO every 4-6 hours PRN pain scale 4-6 pain 3. Percocet 2 tabs PO every 7-10 hours PRN pain scale 7-10 pain 4. Patients will receive dilaudid 0.2mg IV every 3 hours PRN for breakthrough pain. 5. Patients will be discharged home with Motrin and Percocet for pain PRN.
POD4 Satisfaction Score
10.0 Score on a scale
Interval 5.8 to 10.0
8.0 Score on a scale
Interval 6.0 to 10.0

SECONDARY outcome

Timeframe: Up to post op day 4

Population: Patients that have undergone procedure were observed to see when they had their first bowel movement post-operation up to 4 days. 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).

Time to first bowel movement in days

Outcome measures

Outcome measures
Measure
"ICE-T" Opioid Sparing Regimen
n=29 Participants
At the end of surgery patients will receive 30mg of intravenous (IV) toradol. Once out of the post anesthesia care unit (PACU) patients will receive 1. ICE PACKS applied to the surgical sites every hour for 20 minutes Around the clock (ATC) until discharge. 2. 6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge. 3. Once out of the PACU will receive 1 gram of Tylenol per os (PO) every 6 hours for a total of 4 grams daily ATC until discharge 4. Patients will receive dilaudid 0.2mg IV every 3 hours as needed (PRN) for breakthrough pain. 5. Patients will be discharged home with (PO) Tylenol and PO toradol as needed (PRN). 6. If patient's requested additional opioids prior to POD4 they were given a supplemental narcotic prescription to ensure adequate pain control
STANDARD Postoperative Regimen
n=23 Participants
Once out of the PACU patients will receive "Standard" postoperative regimen, which includes: 1. Motrin 600mg PO every 4 hours PRN pain scale 1-3 pain 2. Percocet 1 tab PO every 4-6 hours PRN pain scale 4-6 pain 3. Percocet 2 tabs PO every 7-10 hours PRN pain scale 7-10 pain 4. Patients will receive dilaudid 0.2mg IV every 3 hours PRN for breakthrough pain. 5. Patients will be discharged home with Motrin and Percocet for pain PRN.
Time to First Bowel Movement
2 days
Interval 1.0 to 3.0
3 days
Interval 2.0 to 4.0

SECONDARY outcome

Timeframe: Data collected as of Postoperative day 4

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).

The number of oxycodone 5mg doses (whether as oxycodone 5mg or as percocet 5/325) taken since discharge up until postoperative 4.

Outcome measures

Outcome measures
Measure
"ICE-T" Opioid Sparing Regimen
n=29 Participants
At the end of surgery patients will receive 30mg of intravenous (IV) toradol. Once out of the post anesthesia care unit (PACU) patients will receive 1. ICE PACKS applied to the surgical sites every hour for 20 minutes Around the clock (ATC) until discharge. 2. 6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge. 3. Once out of the PACU will receive 1 gram of Tylenol per os (PO) every 6 hours for a total of 4 grams daily ATC until discharge 4. Patients will receive dilaudid 0.2mg IV every 3 hours as needed (PRN) for breakthrough pain. 5. Patients will be discharged home with (PO) Tylenol and PO toradol as needed (PRN). 6. If patient's requested additional opioids prior to POD4 they were given a supplemental narcotic prescription to ensure adequate pain control
STANDARD Postoperative Regimen
n=23 Participants
Once out of the PACU patients will receive "Standard" postoperative regimen, which includes: 1. Motrin 600mg PO every 4 hours PRN pain scale 1-3 pain 2. Percocet 1 tab PO every 4-6 hours PRN pain scale 4-6 pain 3. Percocet 2 tabs PO every 7-10 hours PRN pain scale 7-10 pain 4. Patients will receive dilaudid 0.2mg IV every 3 hours PRN for breakthrough pain. 5. Patients will be discharged home with Motrin and Percocet for pain PRN.
Oxycodone 5mg Doses Taken Since Discharge
0 Doses
Interval 0.0 to 1.0
7.0 Doses
Interval 3.0 to 12.0

OTHER_PRE_SPECIFIED outcome

Timeframe: Up until postoperative day 4

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).

Enrolled patients were randomized at the end of surgery to 1 of 2 postoperative pain regimens: ICE-T opioid-sparing regimen or the Standard opioid-centric regimen. The pain regimen protocols began upon PACU discharge. Subjects received their regimens as assigned, except that patients assigned to the ICE-T opioid-sparing group who requested additional narcotic medications prior to postoperative day 4 were prescribed supplemental opioids in addition to their ICE-T regimen medications.

Outcome measures

Outcome measures
Measure
"ICE-T" Opioid Sparing Regimen
n=29 Participants
At the end of surgery patients will receive 30mg of intravenous (IV) toradol. Once out of the post anesthesia care unit (PACU) patients will receive 1. ICE PACKS applied to the surgical sites every hour for 20 minutes Around the clock (ATC) until discharge. 2. 6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge. 3. Once out of the PACU will receive 1 gram of Tylenol per os (PO) every 6 hours for a total of 4 grams daily ATC until discharge 4. Patients will receive dilaudid 0.2mg IV every 3 hours as needed (PRN) for breakthrough pain. 5. Patients will be discharged home with (PO) Tylenol and PO toradol as needed (PRN). 6. If patient's requested additional opioids prior to POD4 they were given a supplemental narcotic prescription to ensure adequate pain control
STANDARD Postoperative Regimen
Once out of the PACU patients will receive "Standard" postoperative regimen, which includes: 1. Motrin 600mg PO every 4 hours PRN pain scale 1-3 pain 2. Percocet 1 tab PO every 4-6 hours PRN pain scale 4-6 pain 3. Percocet 2 tabs PO every 7-10 hours PRN pain scale 7-10 pain 4. Patients will receive dilaudid 0.2mg IV every 3 hours PRN for breakthrough pain. 5. Patients will be discharged home with Motrin and Percocet for pain PRN.
"ICE-T" Arm Patients Who Requested Supplemental Narcotics in Addition to Their ICE-T Regimen
8 Participants

Adverse Events

"ICE-T" Opioid Sparing Regimen

Serious events: 0 serious events
Other events: 7 other events
Deaths: 0 deaths

STANDARD Postoperative Regimen

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
"ICE-T" Opioid Sparing Regimen
n=36 participants at risk
At the end of surgery patients will receive 30mg of intravenous (IV) toradol. Once out of the post anesthesia care unit (PACU) patients will receive 1. ICE PACKS applied to the surgical sites every hour for 20 minutes Around the clock (ATC) until discharge. 2. 6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge. 3. Once out of the PACU will receive 1 gram of Tylenol per os (PO) every 6 hours for a total of 4 grams daily ATC until discharge 4. Patients will receive dilaudid 0.2mg IV every 3 hours as needed (PRN) for breakthrough pain. 5. Patients will be discharged home with (PO) Tylenol and PO toradol as needed (PRN). 6. If patients requested additional opioids prior to POD4 they were given a supplemental narcotic prescription to ensure adequate pain control
STANDARD Postoperative Regimen
n=30 participants at risk
Once out of the PACU patients will receive "Standard" postoperative regimen, which includes: 1. Motrin 600mg PO every 4 hours PRN pain scale 1-3 pain 2. Percocet 1 tab PO every 4-6 hours PRN pain scale 4-6 pain 3. Percocet 2 tabs PO every 7-10 hours PRN pain scale 7-10 pain 4. Patients will receive dilaudid 0.2mg IV every 3 hours PRN for breakthrough pain. 5. Patients will be discharged home with Motrin and Percocet for pain PRN.
Injury, poisoning and procedural complications
Intraoperative Complication: Cystotomy
8.3%
3/36 • Number of events 3 • Follow up was until postoperative day 4 (POD 4)
Adverse event data was collected from the time of operation up to postoperative day 4. This was systematically collected via chart review, as well as a questionnaire administered to patients via phone in order to capture any events treated outside the study institution.
3.3%
1/30 • Number of events 1 • Follow up was until postoperative day 4 (POD 4)
Adverse event data was collected from the time of operation up to postoperative day 4. This was systematically collected via chart review, as well as a questionnaire administered to patients via phone in order to capture any events treated outside the study institution.
Gastrointestinal disorders
Emergency Room Visit Post-Operatively - Constipation
0.00%
0/36 • Follow up was until postoperative day 4 (POD 4)
Adverse event data was collected from the time of operation up to postoperative day 4. This was systematically collected via chart review, as well as a questionnaire administered to patients via phone in order to capture any events treated outside the study institution.
3.3%
1/30 • Number of events 1 • Follow up was until postoperative day 4 (POD 4)
Adverse event data was collected from the time of operation up to postoperative day 4. This was systematically collected via chart review, as well as a questionnaire administered to patients via phone in order to capture any events treated outside the study institution.
Injury, poisoning and procedural complications
Emergency Room Visit Post-operatively - Pain
2.8%
1/36 • Number of events 1 • Follow up was until postoperative day 4 (POD 4)
Adverse event data was collected from the time of operation up to postoperative day 4. This was systematically collected via chart review, as well as a questionnaire administered to patients via phone in order to capture any events treated outside the study institution.
3.3%
1/30 • Number of events 1 • Follow up was until postoperative day 4 (POD 4)
Adverse event data was collected from the time of operation up to postoperative day 4. This was systematically collected via chart review, as well as a questionnaire administered to patients via phone in order to capture any events treated outside the study institution.
Injury, poisoning and procedural complications
Emergency Room Visit - Intraoperative complication
5.6%
2/36 • Number of events 2 • Follow up was until postoperative day 4 (POD 4)
Adverse event data was collected from the time of operation up to postoperative day 4. This was systematically collected via chart review, as well as a questionnaire administered to patients via phone in order to capture any events treated outside the study institution.
0.00%
0/30 • Follow up was until postoperative day 4 (POD 4)
Adverse event data was collected from the time of operation up to postoperative day 4. This was systematically collected via chart review, as well as a questionnaire administered to patients via phone in order to capture any events treated outside the study institution.
Injury, poisoning and procedural complications
Intraoperative complication: bowel repair
2.8%
1/36 • Number of events 1 • Follow up was until postoperative day 4 (POD 4)
Adverse event data was collected from the time of operation up to postoperative day 4. This was systematically collected via chart review, as well as a questionnaire administered to patients via phone in order to capture any events treated outside the study institution.
0.00%
0/30 • Follow up was until postoperative day 4 (POD 4)
Adverse event data was collected from the time of operation up to postoperative day 4. This was systematically collected via chart review, as well as a questionnaire administered to patients via phone in order to capture any events treated outside the study institution.

Additional Information

Dr. Robert Pollard

Metrohealth System

Phone: 2167781446

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place